+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Fusion Biopsy Market by Product Type, Procedure Type, Application, End-User - Global Forecast to 2030- Product Image
Fusion Biopsy Market by Product Type, Procedure Type, Application, End-User - Global Forecast to 2030- Product Image
Sale

Fusion Biopsy Market by Product Type, Procedure Type, Application, End-User - Global Forecast to 2030

  • PDF Icon

    Report

  • 185 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6090089
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Fusion Biopsy Market grew from USD 751.72 million in 2024 to USD 806.29 million in 2025. It is expected to continue growing at a CAGR of 7.51%, reaching USD 1.16 billion by 2030.

Navigating the Fusion Biopsy Frontier

The fusion biopsy arena has undergone a remarkable evolution, integrating advanced imaging modalities to enhance diagnostic precision and patient outcomes. By combining real-time ultrasound with high-resolution MRI guidance, fusion biopsy has emerged as a transformative technique in tissue sampling, reducing false negatives and enabling early detection of conditions across multiple medical disciplines. As medical imaging technologies mature and interoperability between devices improves, fusion biopsy is becoming a cornerstone of minimally invasive diagnostics. The convergence of hardware sophistication and software-driven image processing has elevated clinical confidence, fostering broader adoption among interventional radiologists and urologists. This introduction sets the stage for a deeper exploration of the forces shaping the market, its segmentation dynamics, and strategic considerations for stakeholders aiming to capitalize on this growth trajectory.

Revolutionary Shifts Redefining Fusion Biopsy Practice

A confluence of technological breakthroughs and shifting clinical priorities is redefining the fusion biopsy landscape. Artificial intelligence-powered image analysis now enhances lesion targeting, reducing procedure times and streamlining clinician workflows. Meanwhile, advances in hybrid imaging platforms have lowered barriers to adoption by consolidating the footprint of MRI-ultrasound fusion systems in outpatient settings. Regulatory bodies are responding by accelerating approvals for integrated devices, reflecting a broader move to expedite patient access to innovative diagnostics. Concurrently, patient-centric care models are placing a premium on minimally invasive approaches, bolstering demand for fusion biopsy as a safer alternative to surgical exploration. These dynamics collectively signal a transformational phase, wherein innovation and policy converge to propel fusion biopsy into mainstream clinical practice.

Navigating US Tariff Pressures on Fusion Biopsy Innovations

The landscape of medical device trade has been recalibrated by the imposition of new tariffs, altering the cost structure for key fusion biopsy technologies. Equipment manufacturers reliant on imported components face upward pressure on capital expenditures, prompting a reassessment of pricing strategies. At the same time, supply chain diversification has emerged as a critical response, with firms increasingly sourcing parts domestically to mitigate tariff-induced volatility. This recalibration is also catalyzing partnerships between original equipment manufacturers and local contract producers, helping to contain unit costs while preserving throughput. Despite the challenges of tariff pass-through, there are emerging opportunities in localized manufacturing initiatives that promise to strengthen regional innovation ecosystems. As a result, stakeholders who proactively adapt their sourcing and production strategies will gain a competitive edge in controlling costs without compromising on technological sophistication.

Granular Insights into Fusion Biopsy Market Divisions

Dissecting the market by product type reveals a bifurcated structure, where consumables such as biopsy markers, contrast agents, needles and probes, as well as sterilization and disinfection kits account for recurring revenue streams, while capital-intensive equipment segments centered on hybrid MRI-ultrasound systems, MRI-based platforms and ultrasound-based devices drive headline investments. This dual-pathway model underscores the importance of balancing innovation in durable systems with ongoing support for disposable supplies. When viewed through the lens of procedure type, the transperineal and transrectal approaches continue to jockey for preference, each offering distinct clinical benefits and risk profiles that influence adoption trends across regions. Examining application-based usage, cardiovascular diseases, infectious conditions, neurological assessments and oncology each leverage fusion biopsy in unique protocols, reflecting the technology’s versatility. Finally, end users ranging from diagnostic centers and hospitals to specialty clinics exhibit varied procurement cycles and capital allocation strategies, necessitating tailored value propositions to meet divergent operational imperatives.

Regional Dynamics Shaping Fusion Biopsy Adoption

Regional dynamics are pivotal in shaping the diffusion of fusion biopsy technology across global healthcare markets. In the Americas, robust reimbursement frameworks and an established network of academic centers have accelerated early adoption, while collaborative research initiatives continue to drive incremental refinements in technique and instrumentation. Europe, the Middle East and Africa present a mosaic of regulatory environments, where markets such as the United Kingdom and Germany showcase rapid uptake, juxtaposed against emerging economies that are building foundational imaging infrastructure. Meanwhile, the Asia-Pacific region is witnessing surging interest owing to expanding healthcare investments, a growing prevalence of chronic diseases and the emergence of local manufacturing hubs. Each geography offers distinct channels for growth, and stakeholders must navigate regulatory nuances and infrastructure disparities to deploy effective market entry and expansion strategies.

Spotlight on Pioneers Steering Fusion Biopsy Innovation

Leading innovators are charting the course of fusion biopsy’s next chapter through targeted product launches, strategic alliances and selective acquisitions. Industry frontrunners are enhancing system interoperability to provide turnkey solutions, while specialized players are differentiating through niche consumable portfolios designed for specific clinical applications. Collaborative research agreements between device manufacturers and academic medical centers are fostering a pipeline of next-generation image fusion algorithms, positioning these entities at the vanguard of precision diagnostics. Meanwhile, competitive positioning is being reshaped by the integration of digital platforms that enable remote procedure planning and real-time data analytics. This confluence of strategic initiatives underscores a competitive landscape in which technological leadership and ecosystem partnerships define market winners.

Strategic Imperatives for Fusion Biopsy Industry Leaders

To secure a leadership position in the evolving fusion biopsy ecosystem, industry players must pursue three strategic imperatives. First, investment in R&D should be directed toward artificial intelligence-driven image registration and automation features that reduce procedure complexity and enhance clinical throughput. Second, forging end-to-end partnerships with healthcare providers will ensure seamless integration of devices, consumables and digital services, creating sticky customer relationships. Third, geographic diversification should prioritize markets where reimbursement policies and healthcare infrastructure align with adoption drivers, enabling a balanced portfolio of mature and emerging regions. By executing on these fronts, organizations can build resilient models that navigate regulatory headwinds, tariff fluctuations and shifting provider preferences, ultimately driving sustained market share gains.

Research Framework Guiding Fusion Biopsy Intelligence

This analysis is underpinned by a robust research framework combining qualitative expertise and quantitative validation. Primary insights were collected through in-depth interviews with clinicians, procurement managers and technical leaders across diagnostic centers, hospitals and specialty clinics. Secondary data sources included regulatory filings, peer-reviewed publications and industry association reports, which were rigorously cross-referenced to ensure consistency. A multi-stage triangulation process integrated supply-side and demand-side metrics to refine segmentation and regional trends. Throughout, methodological rigor was maintained by applying standard data-cleaning protocols and benchmarking against historical performance indicators, yielding a comprehensive view that informs strategic decision-making without reliance on speculative forecasting.

Summative Insights into the Fusion Biopsy Trajectory

In summary, fusion biopsy has matured into a pivotal diagnostic technology, propelled by innovations in hybrid imaging systems, consumable design and digital enhancements. The imposition of new trade tariffs has introduced cost considerations that are reshaping supply chain strategies, while market segmentation highlights the importance of tailored approaches for product, procedure, application and end-user dynamics. Regional heterogeneity underscores the need for geographically nuanced execution, as does competitive activity that continues to raise the bar for technological integration. As the market enters its next phase, stakeholders who blend technological prowess with adaptive commercial models will be best positioned to harness the full potential of fusion biopsy advancements.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Consumables
      • Biopsy Markers
      • Contrast Agents
      • Needles & Probes
      • Sterilization and Disinfection Kits
    • Equipment
      • Hybrid MRI-Ultrasound systems
      • MRI-based systems
      • Ultrasound-based systems
  • Procedure Type
    • Transperineal Approach
    • Transrectal Approach
  • Application
    • Cardiovascular Diseases
    • Infectious Diseases
    • Neurology
    • Oncology
  • End-User
    • Diagnostic Centers
    • Hospitals
    • Specialty Clinics
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Biobot Surgical Pte Ltd
  • Canon Inc.
  • Eigen Technologies, Inc. by Sirion
  • Esaote SpA
  • Exact Imaging, Inc.
  • Focal Healthcare
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies Inc.
  • Hologic, Inc.
  • Invivo Corporation
  • KOELIS
  • Koninklijke Philips N.V.
  • MedCom GmbH
  • MTT GmbH
  • Siemens Healthineers AG
  • UC-Care Medical Systems

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
3.1. Comprehensive overview of the fusion biopsy market evolution significance and current expansion challenges
3.2. In-depth analysis of fusion biopsy consumer preferences competitive dynamics and regulatory landscape
3.3. Evaluation of fusion biopsy market maturity intellectual property landscape and commercialization strategies
3.4. Future outlook of the fusion biopsy market emerging technological trends and growth opportunities
4. Market Overview
4.1. Introduction
4.1.1. Comprehensive Scope and Definition of the Fusion Biopsy Market with Key Growth Drivers Emerging Opportunities and Strategic Recommendations
4.1.2. In-Depth Geographic Overview Covering Americas Europe Middle East Africa and Asia-Pacific Trade Dynamics and Market Penetration Influences
4.1.3. Recent Developments and Regulatory Trends Including Patents Research Collaborations Investments and Industry Events from 2023 to 2025
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Regulatory approvals and reimbursement policies supporting fusion biopsy adoption
5.1.1. Trend Definition and Context Explaining Regulatory Approvals and Reimbursement Policies in Fusion Biopsy Adoption
5.1.2. Impact of Regulatory Approvals and Reimbursement Policies on Market Growth Dynamics and Business Opportunities in Fusion Biopsy
5.1.3. Future Outlook and Strategic Implications of Regulatory Approvals and Reimbursement Policies on Fusion Biopsy Market
5.2. Investments in fusion biopsy devices accelerating market growth and innovation
5.2.1. Comprehensive definition and contextual background of investments in fusion biopsy devices shaping market dynamics
5.2.2. In-depth analysis of market impact from accelerating investments in fusion biopsy device innovation and growth
5.2.3. Future outlook, long-term implications, and strategic recommendations for stakeholders amidst fusion biopsy technology investments
5.3. Advancements in real-time imaging technologies driving fusion biopsy market growth
5.3.1. Comprehensive definition and contextual background of advancements in real-time imaging technologies in fusion biopsy
5.3.2. How advancements in real-time imaging technologies are transforming the fusion biopsy market landscape and enabling new growth opportunities
5.3.3. Future outlook implications and strategic recommendations for stakeholders regarding real-time imaging advancements in fusion biopsy
5.4. Growing focus on personalized medicine driving innovation in fusion biopsy applications
5.4.1. Comprehensive definition and contextual background of personalized medicine driving fusion biopsy innovation
5.4.2. Analysis of how personalized medicine innovation transforms fusion biopsy market dynamics
5.4.3. Future outlook and strategic implications of personalized medicine driven fusion biopsy innovation
5.5. Integration of artificial intelligence enhancing image-guided fusion biopsy procedures
5.5.1. Detailed definition and context of AI integration enhancing image-guided fusion biopsy procedures
5.5.2. In-depth analysis of market transformation and opportunity expansion due to AI-driven enhancements in fusion biopsy
5.5.3. Comprehensive outlook on the future development, implications, and challenges of AI in image-guided fusion biopsy
5.6. Advancements in minimally invasive fusion biopsy techniques improving patient outcomes
5.6.1. Trend Definition & Context Explaining the Emergence and Key Characteristics of Minimally Invasive Fusion Biopsy Techniques
5.6.2. Market Impact Analyzing How Innovations in Minimally Invasive Fusion Biopsy Techniques Are Reshaping Market Dynamics and Creating Growth Opportunities
5.6.3. Future Outlook & Implications Discussing The Long-Term Trajectory, Risks, and Strategic Recommendations for Stakeholders
5.7. Collaborations among tech companies and healthcare providers potimizing fusion biopsy workflows
5.7.1. Comprehensive definition and contextual background of collaborations optimizing fusion biopsy workflows
5.7.2. Detailed examination of market impact and opportunities driven by tech-healthcare collaborations
5.7.3. Future trajectory and strategic implications of tech-healthcare collaborations in fusion biopsy
5.8. Development of portable and user-friendly fusion biopsy systems for outpatient settings
5.8.1. Trend Definition and Context of Portable and User-Friendly Fusion Biopsy Systems in Outpatient Settings
5.8.2. Market Impact of the Development of Portable and User-Friendly Fusion Biopsy Systems for Outpatient Settings
5.8.3. Future Outlook and Implications for the Development of Portable Fusion Biopsy Systems in Outpatient Settings
5.9. Expanding use of real-time imaging fusion guiding targeted biopsy procedures
5.9.1. Trend Definition and Context Highlighting the Integration of Real-time Imaging Fusion in Biopsy Procedures
5.9.2. Analyzing Market Impact Driven by Real-time Imaging Fusion in Targeted Biopsy Procedures
5.9.3. Future Outlook and Implications of Expanding Real-time Imaging Fusion for Targeted Biopsy Procedures
5.10. Increasing adoption of MRI-ultrasound fusion biopsy in prostate cancer detection and management
5.10.1. Trend Definition and Context Clearly Defining the Increasing Adoption of MRI-Ultrasound Fusion Biopsy in Prostate Cancer Detection and Management
5.10.2. Market Impact Analysis Detailing How the Increasing Adoption of MRI-Ultrasound Fusion Biopsy Is Transforming the Prostate Cancer Detection Market
5.10.3. Future Outlook and Implications of Increasing Adoption of MRI-Ultrasound Fusion Biopsy in Prostate Cancer Detection and Management
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.1.1. Assessing the substantial barriers that lower the likelihood of newcomers entering the fusion biopsy market
6.1.2. Evaluating how emerging technologies and diagnostic alternatives influence substitution risks in the fusion biopsy market
6.1.3. Analyzing moderate supplier influence due to specialized inputs and industry partnerships in the fusion biopsy market
6.1.4. Examining how concentrated healthcare buyers with alternatives exert high bargaining power in the fusion biopsy market
6.1.5. Assessing intense competition driven by innovation and strategic positioning in the fusion biopsy market
6.2. PESTLE Analysis
6.2.1. Political factors impacting fusion biopsy market access, regulatory approvals, and healthcare policies
6.2.2. Economic trends influencing healthcare spending, inflation, and patient affordability in fusion biopsy market
6.2.3. Social dynamics driving awareness, demographic changes, and ethical considerations in fusion biopsy market
6.2.4. Technological innovations in imaging, AI integration, and minimally invasive techniques driving fusion biopsy advancements
6.2.5. Legal environment shaping regulatory compliance, data privacy, and intellectual property protection in fusion biopsy
6.2.6. Environmental pressures encouraging sustainable practices, waste reduction, and operational resilience in fusion biopsy market
7. Cumulative Impact of United States Tariffs 2025
7.1. Understanding the Historical Background and Economic Motivations Behind U.S. Tariff Policies from 2018 to 2025
7.2. Examining the Direct Inflationary Effects of U.S. Tariff Implementations on the Global Economy Since 2023
7.3. Analyzing Reciprocal Tariffs and Emerging Trade Wars Between the U.S. and Its Global Trading Partners
7.4. Assessing the Economic and Political Consequences of U.S. Tariffs on Major International Trade Partners
7.5. Identifying Long-Term Structural Changes in the U.S. Economy Driven by Tariff Policies and Their Effects on Consumer Behavior
7.6. Proposing Policy Responses and Strategies to Mitigate the Negative Economic Impact of Tariffs on the U.S. and Its Trading Partners
8. Fusion Biopsy Market, by Product Type
8.1. Introduction
8.2. Consumables
8.2.1. Biopsy Markers
8.2.2. Contrast Agents
8.2.3. Needles & Probes
8.2.4. Sterilization and Disinfection Kits
8.3. Equipment
8.3.1. Hybrid MRI-Ultrasound systems
8.3.2. MRI-based systems
8.3.3. Ultrasound-based systems
9. Fusion Biopsy Market, by Procedure Type
9.1. Introduction
9.2. Transperineal Approach
9.3. Transrectal Approach
10. Fusion Biopsy Market, by Application
10.1. Introduction
10.2. Cardiovascular Diseases
10.3. Infectious Diseases
10.4. Neurology
10.5. Oncology
11. Fusion Biopsy Market, by End-User
11.1. Introduction
11.2. Diagnostic Centers
11.3. Hospitals
11.4. Specialty Clinics
12. Americas Fusion Biopsy Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Fusion Biopsy Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Fusion Biopsy Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Biobot Surgical Pte Ltd
15.3.1.1. In-depth analysis of Biobot Surgical's flagship fusion biopsy products and services addressing target market needs
15.3.1.2. Comprehensive risk and vulnerability assessment with strategic improvement recommendations for future growth
15.3.2. Canon Inc.
15.3.2.1. Comprehensive Analysis of Canon Inc.'s Flagship Products and Services Aligning with Market Needs
15.3.2.2. In-Depth Risk Assessment and Strategic Recommendations to Strengthen Canon Inc.'s Market Position and Product Portfolio
15.3.3. Eigen Technologies, Inc. by Sirion
15.3.3.1. In-depth Analysis of Eigen Technologies' Flagship Products and Services and Their Market Impact
15.3.3.2. Comprehensive Risk and Vulnerability Assessment with Actionable Strategies for Eigen Technologies' Growth
15.3.4. Esaote SpA
15.3.4.1. Comprehensive analysis of flagship products and services catering to target market needs with unique features and benefits
15.3.4.2. In-depth risk and vulnerability assessment with actionable strategies for growth and market enhancement in the evolving healthcare technology landscape
15.3.5. Exact Imaging, Inc.
15.3.5.1. Comprehensive overview of Exact Imaging, Inc.'s market positioning, growth trajectory, and core capabilities
15.3.5.2. In-depth analysis of Exact Imaging, Inc.'s flagship fusion biopsy technology and market differentiation
15.3.5.3. Comprehensive risk evaluation and strategic recommendations for sustaining Exact Imaging, Inc.'s market growth and innovation
15.3.6. Focal Healthcare
15.3.6.1. In-depth analysis of Focal Healthcare's flagship fusion biopsy products and their alignment with market demands
15.3.6.2. Comprehensive risk assessment and strategies to enhance Focal Healthcare's market growth and product diversification
15.3.7. Fujifilm Holdings Corporation
15.3.7.1. Comprehensive overview of Fujifilm Holdings Corporation's market role and strategic positioning with a focus on its evolution and geographic influence
15.3.7.2. In-depth analysis of Fujifilm's leading products and services tailored to key market demands highlighting unique differentiators and technological edge
15.3.7.3. Assessment of Fujifilm’s risk exposure and vulnerabilities with strategic recommendations to fortify market growth and innovation trajectory
15.3.8. GE HealthCare Technologies Inc.
15.3.8.1. Introduction to GE HealthCare Technologies Inc in the Global Healthcare Market and Its Strategic Positioning with Core Strengths
15.3.8.2. In-depth Analysis of GE HealthCare's Flagship Products and Services and Their Competitive Advantages
15.3.8.3. Comprehensive Risk and Vulnerability Assessment for GE HealthCare with Strategic Recommendations for Future Growth
15.3.9. Hologic, Inc.
15.3.9.1. Focused Overview of Hologic’s Current Role, Market Positioning, and Strategic Strength in the Global Healthcare Landscape
15.3.9.2. Detailed Identification and Analysis of Hologic’s Flagship Products and Services within the Market
15.3.9.3. Comprehensive Risk and Vulnerability Assessment Alongside Strategies to Enhance Hologic’s Market Position and Adapt to Emerging Trends
15.3.10. Invivo Corporation
15.3.10.1. Comprehensive Examination of Invivo Corporation's Flagship Products and Services Tailored to Fusion Biopsy Market Needs
15.3.10.2. Detailed Risk and Vulnerability Assessment with Strategic Action Plans to Strengthen Invivo Corporation’s Market Position and Product Portfolio Growth
15.3.11. KOELIS
15.3.11.1. In-depth analysis of KOELIS's flagship fusion biopsy products and alignment with clinical market demands
15.3.11.2. Comprehensive risk and vulnerability assessment with strategic recommendations for KOELIS's sustainable growth
15.3.12. Koninklijke Philips N.V.
15.3.12.1. Comprehensive Evaluation of Koninklijke Philips N.V.'s Flagship Healthcare Products and Market Alignment
15.3.12.2. In-depth Risk and Vulnerability Assessment with Actionable Strategies for Enhancing Market Position and Product Portfolio
15.3.13. MedCom GmbH
15.3.13.1. In-depth analysis of MedCom GmbH flagship fusion biopsy products that meet evolving medical diagnostic needs
15.3.13.2. Comprehensive risk and vulnerability assessment focusing on strategic growth opportunities for MedCom GmbH
15.3.14. MTT GmbH
15.3.14.1. A Thorough Introduction to MTT GmbH's Strategic Role and Market Presence with Its Core Strengths
15.3.14.2. An In-Depth Analysis of MTT GmbH’s Flagship Fusion Biopsy Products and Their Alignment with Market Needs
15.3.14.3. Comprehensive Risk and Vulnerability Analysis of MTT GmbH with Actionable Strategies for Future Resilience
15.3.15. Siemens Healthineers AG
15.3.15.1. In-depth analysis of Siemens Healthineers flagship products and services highlighting market alignment and competitive advantages
15.3.15.2. Comprehensive risk and vulnerability assessment with actionable strategies for growth and market adaptation over the next years
15.3.16. UC-Care Medical Systems
15.3.16.1. Analyze UC-Care Medical Systems’ Flagship Fusion Biopsy Products and Services That Define Its Market Leadership
15.3.16.2. Comprehensive Risk Assessment and Strategic Recommendations for UC-Care Medical Systems to Secure Market Growth and Innovation
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. FUSION BIOPSY MARKET MULTI-CURRENCY
FIGURE 2. FUSION BIOPSY MARKET MULTI-LANGUAGE
FIGURE 3. FUSION BIOPSY MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL FUSION BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL FUSION BIOPSY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL FUSION BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL FUSION BIOPSY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL FUSION BIOPSY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL FUSION BIOPSY MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL FUSION BIOPSY MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS FUSION BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS FUSION BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES FUSION BIOPSY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES FUSION BIOPSY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA FUSION BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA FUSION BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC FUSION BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC FUSION BIOPSY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. FUSION BIOPSY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. FUSION BIOPSY MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. FUSION BIOPSY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL FUSION BIOPSY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL FUSION BIOPSY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL FUSION BIOPSY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL FUSION BIOPSY MARKET SIZE, BY BIOPSY MARKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL FUSION BIOPSY MARKET SIZE, BY CONTRAST AGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL FUSION BIOPSY MARKET SIZE, BY NEEDLES & PROBES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL FUSION BIOPSY MARKET SIZE, BY STERILIZATION AND DISINFECTION KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL FUSION BIOPSY MARKET SIZE, BY HYBRID MRI-ULTRASOUND SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL FUSION BIOPSY MARKET SIZE, BY MRI-BASED SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL FUSION BIOPSY MARKET SIZE, BY ULTRASOUND-BASED SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL FUSION BIOPSY MARKET SIZE, BY TRANSPERINEAL APPROACH, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL FUSION BIOPSY MARKET SIZE, BY TRANSRECTAL APPROACH, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL FUSION BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL FUSION BIOPSY MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL FUSION BIOPSY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL FUSION BIOPSY MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL FUSION BIOPSY MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL FUSION BIOPSY MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL FUSION BIOPSY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL FUSION BIOPSY MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS FUSION BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS FUSION BIOPSY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES FUSION BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES FUSION BIOPSY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 44. CANADA FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 45. CANADA FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 46. CANADA FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 47. CANADA FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 48. CANADA FUSION BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. CANADA FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 50. MEXICO FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 51. MEXICO FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 52. MEXICO FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 53. MEXICO FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 54. MEXICO FUSION BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. MEXICO FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 56. BRAZIL FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL FUSION BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA FUSION BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 68. EUROPE, MIDDLE EAST & AFRICA FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 72. EUROPE, MIDDLE EAST & AFRICA FUSION BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. EUROPE, MIDDLE EAST & AFRICA FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA FUSION BIOPSY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 75. UNITED KINGDOM FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 76. UNITED KINGDOM FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 77. UNITED KINGDOM FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 78. UNITED KINGDOM FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 79. UNITED KINGDOM FUSION BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. UNITED KINGDOM FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. GERMANY FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 82. GERMANY FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 83. GERMANY FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 84. GERMANY FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 85. GERMANY FUSION BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. GERMANY FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 87. FRANCE FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 88. FRANCE FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 89. FRANCE FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 90. FRANCE FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 91. FRANCE FUSION BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. FRANCE FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. RUSSIA FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 94. RUSSIA FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 95. RUSSIA FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 96. RUSSIA FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 97. RUSSIA FUSION BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. RUSSIA FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. ITALY FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 100. ITALY FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 101. ITALY FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 102. ITALY FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 103. ITALY FUSION BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. ITALY FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. SPAIN FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 106. SPAIN FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 107. SPAIN FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 108. SPAIN FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 109. SPAIN FUSION BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. SPAIN FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 111. UNITED ARAB EMIRATES FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 112. UNITED ARAB EMIRATES FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 113. UNITED ARAB EMIRATES FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 114. UNITED ARAB EMIRATES FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 115. UNITED ARAB EMIRATES FUSION BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. UNITED ARAB EMIRATES FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 117. SAUDI ARABIA FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 118. SAUDI ARABIA FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 119. SAUDI ARABIA FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 120. SAUDI ARABIA FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA FUSION BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 123. SOUTH AFRICA FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA FUSION BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 129. DENMARK FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 130. DENMARK FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 131. DENMARK FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 132. DENMARK FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 133. DENMARK FUSION BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. DENMARK FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 135. NETHERLANDS FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS FUSION BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. NETHERLANDS FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 141. QATAR FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 142. QATAR FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 143. QATAR FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 144. QATAR FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 145. QATAR FUSION BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. QATAR FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 147. FINLAND FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 148. FINLAND FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 149. FINLAND FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 150. FINLAND FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 151. FINLAND FUSION BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. FINLAND FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 153. SWEDEN FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 154. SWEDEN FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 155. SWEDEN FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 156. SWEDEN FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 157. SWEDEN FUSION BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. SWEDEN FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 159. NIGERIA FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 160. NIGERIA FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 161. NIGERIA FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 162. NIGERIA FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 163. NIGERIA FUSION BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 164. NIGERIA FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 165. EGYPT FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 166. EGYPT FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 167. EGYPT FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 168. EGYPT FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 169. EGYPT FUSION BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. EGYPT FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 171. TURKEY FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 172. TURKEY FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 173. TURKEY FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 174. TURKEY FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 175. TURKEY FUSION BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. TURKEY FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 177. ISRAEL FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 178. ISRAEL FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 179. ISRAEL FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 180. ISRAEL FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 181. ISRAEL FUSION BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. ISRAEL FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 183. NORWAY FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 184. NORWAY FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 185. NORWAY FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 186. NORWAY FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 187. NORWAY FUSION BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. NORWAY FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 189. POLAND FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 190. POLAND FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 191. POLAND FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 192. POLAND FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 193. POLAND FUSION BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. POLAND FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 195. SWITZERLAND FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 196. SWITZERLAND FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 197. SWITZERLAND FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 198. SWITZERLAND FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 199. SWITZERLAND FUSION BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. SWITZERLAND FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 201. ASIA-PACIFIC FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 202. ASIA-PACIFIC FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 203. ASIA-PACIFIC FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 204. ASIA-PACIFIC FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 205. ASIA-PACIFIC FUSION BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 206. ASIA-PACIFIC FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 207. ASIA-PACIFIC FUSION BIOPSY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 208. CHINA FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 209. CHINA FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 210. CHINA FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 211. CHINA FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 212. CHINA FUSION BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. CHINA FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 214. INDIA FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 215. INDIA FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 216. INDIA FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 217. INDIA FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 218. INDIA FUSION BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 219. INDIA FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 220. JAPAN FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 221. JAPAN FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 222. JAPAN FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 223. JAPAN FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 224. JAPAN FUSION BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 225. JAPAN FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 226. AUSTRALIA FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 227. AUSTRALIA FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 228. AUSTRALIA FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 229. AUSTRALIA FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 230. AUSTRALIA FUSION BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. AUSTRALIA FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 232. SOUTH KOREA FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 233. SOUTH KOREA FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 234. SOUTH KOREA FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 235. SOUTH KOREA FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 236. SOUTH KOREA FUSION BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 237. SOUTH KOREA FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 238. INDONESIA FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 239. INDONESIA FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 240. INDONESIA FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 241. INDONESIA FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 242. INDONESIA FUSION BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 243. INDONESIA FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 244. THAILAND FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 245. THAILAND FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 246. THAILAND FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 247. THAILAND FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 248. THAILAND FUSION BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 249. THAILAND FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 250. PHILIPPINES FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 251. PHILIPPINES FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 252. PHILIPPINES FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 253. PHILIPPINES FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 254. PHILIPPINES FUSION BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 255. PHILIPPINES FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 256. MALAYSIA FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 257. MALAYSIA FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 258. MALAYSIA FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 259. MALAYSIA FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 260. MALAYSIA FUSION BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 261. MALAYSIA FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 262. SINGAPORE FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 263. SINGAPORE FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 264. SINGAPORE FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 265. SINGAPORE FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 266. SINGAPORE FUSION BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 267. SINGAPORE FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 268. VIETNAM FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 269. VIETNAM FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 270. VIETNAM FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 271. VIETNAM FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 272. VIETNAM FUSION BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 273. VIETNAM FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 274. TAIWAN FUSION BIOPSY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 275. TAIWAN FUSION BIOPSY MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 276. TAIWAN FUSION BIOPSY MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
TABLE 277. TAIWAN FUSION BIOPSY MARKET SIZE, BY PROCEDURE TYPE, 2018-2030 (USD MILLION)
TABLE 278. TAIWAN FUSION BIOPSY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 279. TAIWAN FUSION BIOPSY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 280. FUSION BIOPSY MARKET SHARE, BY KEY PLAYER, 2024
TABLE 281. FUSION BIOPSY MARKET, FPNV POSITIONING MATRIX, 2024

Companies Mentioned

The companies profiled in this Fusion Biopsy market report include:
  • Biobot Surgical Pte Ltd
  • Canon Inc.
  • Eigen Technologies, Inc. by Sirion
  • Esaote SpA
  • Exact Imaging, Inc.
  • Focal Healthcare
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies Inc.
  • Hologic, Inc.
  • Invivo Corporation
  • KOELIS
  • Koninklijke Philips N.V.
  • MedCom GmbH
  • MTT GmbH
  • Siemens Healthineers AG
  • UC-Care Medical Systems

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages185
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 806.29 Million
Forecasted Market Value ( USD ) by 2030 $ 1160 Million
Compound Annual Growth Rate7.5%
Regions CoveredGlobal
No. of Companies Mentioned17

Related Topics

Related Reports

Fusion Biopsy Market Size, Share & Trends Analysis Report By Biopsy Route (Transrectal, Transperineal), By End Use (Hospitals, Diagnostic Centers, Ambulatory Care Centers), By Region (North America, Asia Pacific), And Segment Forecasts, 2025 - 2030 - Product Image

Fusion Biopsy Market Size, Share & Trends Analysis Report By Biopsy Route (Transrectal, Transperineal), By End Use (Hospitals, Diagnostic Centers, Ambulatory Care Centers), By Region (North America, Asia Pacific), And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Fusion Biopsy Market by Route Type, Product, Application, End User, and Region - Global Forecast to 2029 - Product Image

Fusion Biopsy Market by Route Type, Product, Application, End User, and Region - Global Forecast to 2029

  • Report
  • 197 Pages
  • Global
From
Fusion Biopsy - Global Strategic Business Report - Product Image

Fusion Biopsy - Global Strategic Business Report

  • Report
  • 277 Pages
  • Global
From
Fusion Biopsy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Fusion Biopsy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 180 Pages
  • Global
From
Fusion Biopsy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Fusion Biopsy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 250 Pages
  • Global
Copyright © 2002-2025 Research and Markets. All Rights Reserved.